CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)

Condition:   Crohn's Disease Intervention:   Drug: Certolizumab Pegol Sponsor:   UCB Biopharma S.P.R.L. Available
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials